Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

At Close

May 1, 2026 3:59:58 PM EDT

227.31USD-0.933%(-2.14)235,407

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-229.45)0

After-hours

May 1, 2026 4:00:30 PM EDT

227.44USD+0.057%(+0.13)2,552

OverviewOptionsHistoricalExchangesShortsMore

open chart

standard

Market Cap

2.76B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

May 7, 2026 (4d)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

190,053

Avg. Vol. 30 Day

231,360

Employees

Market Cap

2,757,135,051

Shares Out.

12,129,405

On/Off Exchange

60%/40%

6 Month Beta

0.91

1 Year Beta

1.00

2 Year Beta

1.01

3 Year Beta

1.00

52 Week Low

98.89

52 Week High

247.38

SMA50

210.35

SMA200

187.07

1 Week

-5.99%

1 Month

+13.89%

3 Month

+14.32%

6 Month

+18.86%

1 Year

+107.80%

2 Year

+207.59%

5 Year

+56.52%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $227.31, and today's volume is 235,407. LGND is down -0.933% today. The 30 day average volume is 231,360. LGND market cap is 2.76B with 12,129,405 shares outstanding.